Ver el código de «Parvovirus B19»

==Background==
*In children: causes [[Erythema infectiosum]] (Fifth disease)
*In transplant patients on immunosuppressive drugs: causes RBC aplasia.
**Short-lived, may not be discovered
**Parvovirus only replicated in erythroid progenitor cells

==Clinical Features==
*[[Erythema infectiosum (fifth disease)]]
*Most contagious during the phase of active viral replication and viral shedding, which occurs approximately 5 to 10 days after exposure and usually lasts approximately 5 days
*Complications
**Arthropathy
**[[Aplastic anemia]]

==Differential Diagnosis==
*[[Roseola]]
*[[Measles]]
*[[Rubella]]
*Enteroviral infections
*Group A Streptococcal infections

==Evaluation==
*Diagnosis is clinical usually through clinical presentation 
*IgM testing is recommended for immunocompromised patients.

==Management==
*Parvovirus is usually self-limiting and requires no further treatment.
*Management should be targeted at reducing symptoms, such as using anti-inflammatory medications for arthropathy or performing transfusions for aplastic anemia.

==Disposition==

==See Also==

==External Links==

==References==
*Fish RM, Massad MG. The Transplant Patient. In: Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD, T. eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill; 2011.
*Place R, Lagoc AT, Mayer TA, Lawlor CJ. Oncology and Hematology Emergencies in Children. In: Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD, T. eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill; 2011
<references/>

[[Category:ID]]